Reported 957,098 shares, unchanged from the prior quarter.
Reported value 61.5%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-03-31 | 65000 |
| 2022-06-30 | 32000 |
| 2022-09-30 | 86000 |
| 2022-12-31 | 40600 |
| 2023-03-31 | 38301 |
| 2023-06-30 | 61858 |
| 2023-09-30 | 68528 |
| 2023-12-31 | 25635 |
| 2024-03-31 | 40340 |
| 2024-06-30 | 8595 |
| 2024-09-30 | 2170 |
| 2024-12-31 | 2274 |
| 2025-03-31 | 3973 |
| 2025-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2025 | Reduced | 0 | -274,000 (-100.0%) | 0 | $0 | 2025-08-14 | |
| Q1 2025 | Unchanged | 274,000 | 0 (0.0%) | < 0.01% | $3,973 | 2025-05-13 | |
| Q4 2024 | Reduced | 274,000 | -151,534 (-35.6%) | < 0.01% | $2,274 | 2025-02-10 | |
| Q3 2024 | Reduced | 425,534 | -2,100 (-0.5%) | < 0.01% | $2,170 | 2024-11-12 | |
| Q2 2024 | Reduced | 427,634 | -163,866 (-27.7%) | < 0.01% | $8,595 | 2024-08-13 | |
| Q1 2024 | Reduced | 591,500 | -365,598 (-38.2%) | 0.01% | $40,340 | 2024-05-13 | |
| Q4 2023 | Unchanged | 957,098 | 0 (0.0%) | < 0.01% | $25,635 | 2024-02-13 | |
| Q3 2023 | Unchanged | 957,098 | 0 (0.0%) | < 0.01% | $68,528 | 2023-11-06 | |
| Q2 2023 | Unchanged | 957,098 | 0 (0.0%) | < 0.01% | $61,858 | 2023-08-14 | |
| Q1 2023 | Unchanged | 957,098 | 0 (0.0%) | < 0.01% | $38,301 | 2023-05-12 | |
| Q4 2022 | Added | 957,098 | +26,300 (2.8%) | < 0.01% | $40,600 | 2023-02-13 | |
| Q3 2022 | Added | 930,798 | +630,998 (210.5%) | < 0.01% | $86,000 | 2022-11-08 | |
| Q2 2022 | Unchanged | 299,800 | 0 (0.0%) | < 0.01% | $32,000 | 2022-08-15 | |
| Q1 2022 | New | 299,800 | +299,800 (0.0%) | < 0.01% | $65,000 | 2022-05-16 |
Who else reported the position
49 managers reported PHOENIX BIOTECH ACQUISITION for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MANGROVE PARTNERS | Unchanged | 163,538 | 0 | 0.12% | $1,782,564 | 7 qtrs |
| Periscope Capital Inc This report | Unchanged | 957,098 | 0 | < 0.01% | $61,858 | 6 qtrs |
| Segantii Capital Management Ltd | Unchanged | 5,000 | 0 | < 0.01% | $54,500 | 7 qtrs |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Added | 714,827 | +136,983 | < 0.01% | $43,604 | 7 qtrs |
| MMCAP International Inc SPC | Unchanged | 375,000 | 0 | < 0.01% | $22,913 | 7 qtrs |
| CANTOR FITZGERALD L P | Unchanged | 363,548 | 0 | < 0.01% | $22,213 | 7 qtrs |
| Saba Capital Management L P | Unchanged | 295,913 | 0 | < 0.01% | $19,368 | 7 qtrs |
| Polar Asset Management Partners Inc | Unchanged | 300,000 | 0 | < 0.01% | $18,330 | 7 qtrs |
| Linden Advisors LP | Unchanged | 249,999 | 0 | < 0.01% | $16,375 | 6 qtrs |
| AQR Arbitrage LLC | Reduced | 246,696 | -286 | < 0.01% | $15,073 | 7 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 14, 2023
- Filing type
- 13F-HR
- Position type
- *W EXP 09/01/202
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 957,098
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.